Nasdaq:US$13.81 (+0.07) | HKEX:HK$21.95 (-0.15) | AIM:£2.27 (-0.06)
Search
EN
简
繁
About Us
Overview
Corporate Information
Board of Directors
Management
Sustainability
Contact Us
What We Do
Overview
Research and Development
Commercialization in China
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Publications
News & Press Releases
Scientific Publications
Mailing List Sign-up
Shareholder Information
Overview
Announcements
Events, Presentations & Circulars
Share Price & Chart
Major Shareholders
Financial Reports & Filings
Analyst Coverage
Listing FAQs for Shareholders
Information for Shareholders
Corporate Governance
AIM Rule 26
Careers
About Us
Overview
Corporate Information
Board of Directors
Management
Sustainability
Contact Us
What We Do
Overview
Research and Development
Commercialization in China
Other Ventures
Key Corporate Partnerships
Pipeline & Products
Overview
Our Products
Our Pipeline
Expanded Access
News & Publications
News & Press Releases
Scientific Publications
Mailing List Sign-up
Shareholder Information
Overview
Announcements
Events, Presentations & Circulars
Share Price & Chart
Major Shareholders
Financial Reports & Filings
Analyst Coverage
Listing FAQs for Shareholders
Information for Shareholders
Corporate Governance
AIM Rule 26
Careers
Shareholder Information
Hutchmed
| Shareholder Information
SHARE PRICE CHART
Nasdaq:HCM
US$13.81
+0.07 | 27 Mar 2023 | 16:00EDT
Market cap (M): US$2,388.51
HKEX:13
HK$21.95
-0.15 | 27 Mar 2023 | 16:08HKT
Market cap (M): HK$18,981.81
London AIM:HCM
£2.27
-0 | 27 Mar 2023 | 16:35BST
Market cap (M): £1,963.04
CORPORATE PRESENTATION
28 Feb 2023
2022 Full Year Financial Results
Read more
See all
Announcements
Latest announcements
Financial Reports
Annual Reports (with 20-F) and Interim Reports
EVENTS, PRESENTATIONS & CIRCULARS
2022 Full Year Financial Results
2023-02-28
Corporate Presentation for Investors
2023-02-01
Company Update: Fruquintinib Development and Commercialization Outside China
2023-01-23
Deutsche Bank ADR Virtual Investor Conference (dbVIC)
2022-11-17
MAJOR SHAREHOLDERS
Directors and Significant Shareholders
Information for Shareholders
Share-related address & contact information
Listing FAQs for Shareholders
Frequently asked questions about HUTCHMED's HKEX, Nasdaq and AIM share listings
SEC Filings
AIM RULE 26 DISCLOSURES
Disclosure reference pursuant to Rule 26 'Company Information' of the AIM Rules of Companies
Warning to Shareholders
Avoiding share fraud
ANALYST COVERAGE
Bloomberg
Cantor Fitzgerald
Goldman Sachs
Barclays
Bank of America Merrill Lynch
Canaccord Genuity
CLSA
Deutsche Bank
Edison
HSBC
Macquarie
Morgan Stanley
Panmure Gordon
Trinity Delta
